WHO vaccine-preventable diseases: monitoring system. 2016 global summary

Last updated 15-July-2016 (15-July-2016)
Next overall update Fall 2016
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 132
GDP / capita (US$): 16'3231 Child (under 5 years) mortality rate: 162

Population data in thousands3

  2015  2014  2013  2012  2011  2000  1990  1980 
Total population 79'109  78'144  77'152  76'157  75'184  65'850  56'169  38'668 
Births 1'350  1'370  1'382  1'384  1'379  1'234  1'836  1'735 
Surviving infants 1'331  1'351  1'361  1'364  1'357  1'199  1'755  1'592 
Pop. less than 5 years 6'855  6'858  6'824  6'744  6'607  6'379  9'346  6'850 
Pop. less than 15 years 18'677  18'378  18'077  17'802  17'579  23'012  25'492  16'831 
Female 15-49 years 23'475  23'374  23'257  23'113  22'930  17'532  12'214  8'487 

Number of reported cases

(Click for retrospective incidence data for Iran (Islamic Republic of))
Diphtheria
ChartChart
  28  13  190  150  132  18  373  139 
Japanese encephalitis
ChartChart
 
Measles
ChartChart ChartChart
  615  99  189  332  73  11'874  5'341  31'130 
Mumps
ChartChart
  10'417 
Pertussis
ChartChart
  145  115  1'415  1'329  650  94  1'230  20'395 
Polio*
ChartChart
  15  80 
Rubella
ChartChart
  45  14  32  30  20  1'154 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
  13  26 
Tetanus (total)**
ChartChart
  11  10  13  18  27  30  86 
Yellow fever
ChartChart
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Iran (Islamic Republic of))
Vaccine year result method % card seen                                                
BCG 1989  92  EPI     99*  99*  99*  99*  99  99  95 
DTP1 1986  94  EPI     99  99  98  98  99  99* 
DTP3 1989  88  EPI     98  99  98  99  99  99*  91  32 
DTP4          98  98 
IPV1         
HepB_BD          96  97  99  96  99  99 
HepB3          98  99  99  98  99  99* 
Hib3          98 
JapEnc         
MCV1          99  99  98  98  99  99*  85  39 
MCV2          98  98  97  97  99  99* 
PCV1         
PCV3         
Pol3 1989  88  EPI     98  99  98  99  99  99*  90  38 
Rota1         
RotaC         
Rubella1          99  99  98  98  99 
TT2plus          25  25  25  95  20  46  63 
PAB         
VAD1         
YFV         
° indicates that more than 1 survey occurred that year.  * indicates the country reported above 100% coverage.

  Next update: Mid July 2017

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Iran (Islamic Republic of))
BCG
ChartChart
  99  99  99  99  99  99  95 
DTP1
ChartChart
  99  99  98  99  99  99  97  57 
DTP3
ChartChart
  98  99  98  99  99  99  91  32 
HepB3
ChartChart
  98  99  99  98  99  99 
HepB_BD
ChartChart
  96  97  99  96  99  99 
Hib3
ChartChart
  98  98 
IPV1
ChartChart
 
MCV1
ChartChart
  99  99  98  98  99  99  85  39 
MCV2
ChartChart
  98  98  97  97  99  99 
PAB
ChartChart
  95  95  95  95  95  82  71 
PCV3
ChartChart
 
Pol3
ChartChart
  98  99  98  99  99  99  90  38 
RCV1
ChartChart
  99  99  98  98  99 
RotaC
ChartChart
 

Number of districts in the country 425  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 100
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2015 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DT 2, 4, 6, 18 months; 6 years; Yes
DTwP 18 months; 6 years; Yes
DTwPHibHepB 2, 4, 6 months Yes
HepB birth; 2, 6 months; Yes doses at 2 and 6 months just for cases could not receive Pertussis vaccine and high risk group, HCWs, Medical students
IPV 4 months; Yes
Influenza_Adult Yes Elderly, chronic illness, pregnant women, health care workers , Haj or other travellers
Influenza_Pediatric Yes and chronic illness
MMR 12, 18 months; Yes
MenAC Yes military
OPV birth; 2, 4, 6, 18 months; 6 years; Yes
Rubella Yes CBAW in pre-pregnancy visits
Td Yes repeated every 10 years - military and pregnant women
Varicella Yes Children with lymphatic and hematologic malignancies and their siblings
YF Yes Travellers to endemic countries

Immunizaton indicators

Indicator Expected answer 2015  2014  2013  2012  2011  2010  2009 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2012-2016  2012-2016  2012-2016  2012-2016  2012-2016  2010-2014  2010-2014 
Nº of districts with microplans that include activities to raise immunization coverage number 10 

System performance

Total Nº districts in country number 425  422  411  405  392  360  356 
Nº districts with DTP3 coverage >=80% number 425  422  411  405  392  360  356 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  100  100  100  100  100 
Nº districts with measles (MCV1) coverage >=95% number 425  422  410  405  387  355  347 
% of districts with MCV1 coverage >=95% From 0 to 100% 100  100  100  100  99  99  97 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes  Yes   
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 100  100  100  100      100 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes   

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2015 revision". New York, 2016.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.